USPTO serial 97289095
IRO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 25, 2023
- Examiner
- RITTNER, HANNO I
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Howard J Shire
Howard J Shire Troutman Pepper Locke LLP875 3rd AvenueNew York, NY 10022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 007 | Industrial machines in the nature of industrial bioreactors for manufacturing scientific and pharmaceutical preparations employing cell cultures; racking specially adapted for bioreactors in the nature of manufacturing equipment for cell culture, cell therapy or gene therapy, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; racking specially adapted for holding cell culture, cell therapy or gene therapy manufacturing equipment; bellows being parts of machines for dispensing fluids, stem cells, cell cultures or cell culture media to or from bioreactors being industrial machines for manufacturing; cassettes for industrial bioreactors and disposable cassettes for industrial bioreactors, each specifically adapted for bioreactors in the nature of manufacturing equipment for cell cultures; structural replacement parts, including disposable parts, specifically adapted for bioreactors in the nature of industrial manufacturing equipment for cell culture, cell therapy or gene therapy; connectors in the nature of manual valves specially adapted for bioreactors for industrial manufacturing of cell culture, cell therapy or gene therapy products; sterile connectors, namely, plastic pipe connectors or needle based connectors made of plastic, being parts of industrial manufacturing apparatus for cell culturing, cell therapy and gene therapy; industrial incubators for manufacturing pharmaceutical and scientific chemical products using cell culture, cell therapy or gene therapy process; industrial incubators in the nature of bioreactors for manufacturing and maintaining cell cultures for transport in commerce; industrial apparatus for creating a controlled environment for cell therapy and gene therapy manufacturing, namely, bioreactors for manufacturing and maintaining cell cultures for transport in commerce; industrial manufacturing machines for adding or removing fluids to or from industrial bioreactors for manufacturing pharmaceuticals for cell and gene therapies; replacement structural parts for all the aforesaid machines | ACTIVE | — |
| 009 | Laboratory manufacturing equipment for cell culture, cell therapy or gene therapy, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Downloadable computer software and application software for operating bioreactors in the field of cell culture, cell therapy, gene therapy; downloadable computer software and application software for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment for cell culture, cell therapy or gene therapy; downloadable computer software and application software for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapy; downloadable computer software and application software for logging data in relation to cell culture, cell therapy or gene therapy; downloadable computer communications software and application software for monitoring patient health; downloadable computer software and application software for uploading data to remote computers to provide information on cell culture, cell therapy or gene therapy; downloadable databases of data in the field of cell culture, cell therapy or gene therapy; disposable parts for bioreactors, namely, disposable plastic, glass, silicon, rubber, thermoplastic and polymer bioreactors for cell culturing; cassettes for bioreactors and disposable cassettes for bioreactors, each specially adapted for bioreactors in the nature of laboratory equipment for cell culturing; disposable scientific equipment and apparatus for cell culture, cell therapy or gene therapy, namely, plastic bioreactors for cell culturing; connectors in the nature of manual valves specially adapted for bioreactors for scientific and research use in developing cell culture, cell therapy or gene therapy products; sterile connectors in the nature of manual and automated valves specially adapted for bioreactors for scientific and research use in developing cell culture, cell therapy or gene therapy products; bellows specially adapted for bioreactors for laboratory scientific and research use for storing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment; bellows specially adapted for bioreactors for laboratory scientific and research use for storing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment for cell culture, cell therapy or gene therapy; bags specially adapted for bioreactors for laboratory scientific and research use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment; bags specially adapted for bioreactors for laboratory scientific and research use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment for cell culture, cell therapy or gene therapy; flexible containers specially adapted for bioreactors for laboratory scientific and research use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment; flexible containers specially adapted for bioreactors for laboratory scientific and research use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment for cell culture, cell therapy or gene therapy; compressible containers specially adapted for bioreactors for laboratory scientific and research use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment; compressible containers specially adapted for bioreactors for laboratory scientific and research use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment for cell culture, cell therapy or gene therapy; vessels, bottles and containers being scientific equipment specially adapted for bioreactors for laboratory scientific and research use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment; vessels, bottles and containers being scientific equipment specially adapted for bioreactors for laboratory scientific and research use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment for cell culture, cell therapy or gene therapy; laboratory equipment, namely, incubators for cell culture, cell therapy or gene therapy; laboratory equipment, namely, incubators for maintaining cell cultures; bioreactor arrays, namely, bioreactors for laboratory use; multiplexed bioreactor systems consisting primarily of bioreactors for laboratory use; aseptic filling and sealing machines for bioreactors, each being bioreactors for laboratory use; bioreactors for cell culture for laboratory research and scientific use; bioreactors for cell and gene therapy for laboratory research and scientific use; scientific apparatus consisting primarily of a handling unit in the nature of a bioreactor for laboratory use for creating a controlled environment for cell culture, cell therapy or gene therapy processing; fixtures especially made for laboratories, namely, cell culture ventilation hood, bio-safety cabinets; laboratory equipment, namely, water baths for laboratory use, cell culture vessels in the nature of glassware for cell culture, cell therapy or gene therapy; disposable bioreactors for cell culture in laboratory scientific research; scientific equipment for filling bioreactors, namely pipettes for laboratory use; replacement structural parts for all the aforesaid laboratory equipment | ACTIVE | — |
| 011 | Electrical heating and cooling equipment, namely, cabinets used to control temperature and humidity heating and proofing for cell cultures or cell culture media for cell culture, cell therapy or gene therapy; electrical equipment, namely, industrial apparatus using air for drying and cleaning components in the pharmaceutical industry; electrical cooling equipment, namely, refrigerators, cooling apparatus and freezers for medical storage purposes; electrical cooling equipment being laboratory freezers | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oribiotech Limited
- Other trademarks owned by Oribiotech Limited
- Other trademarks owned by Oribiotech Limited
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 011
- Similar marks named IRO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 16, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 16, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 16, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 16, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 11, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 11, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 11, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 11, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 11, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 11, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 25, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 25, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 9, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 9, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 19, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 5, 2023 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Mar 31, 2023 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Mar 30, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 16, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 28, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Dec 13, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2022 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Nov 19, 2022 | ALIE | ASSIGNED TO LIE | — |
| Oct 3, 2022 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Mar 4, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 4, 2022 | NWAP | NEW APPLICATION ENTERED | — |